Characteristics of patients who suffer major osteoporotic fractures despite adhering to alendronate treatment: a National Prescription registry study
Research output: Contribution to journal › Journal article › Research › peer-review
Antiresorptive treatment reduces the risk of fractures, but most patients remain at elevated risk. We used health registers to identify predictors of new major osteoporotic fractures in patients adhering to alendronate. Risk factors showed a different pattern than in the general population and included dementia, ulcer disease, and Parkinson's disease.
Original language | English |
---|---|
Journal | Osteoporosis International |
Volume | 24 |
Issue number | 1 |
Pages (from-to) | 321-8 |
Number of pages | 8 |
ISSN | 0937-941X |
DOIs | |
Publication status | Published - 2013 |
ID: 48413673